Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain)

American Journal of Gastroenterology

Volumn 91, Issue 5, 1996, Pages 935-941

  Tefera, S ^b   Berstad, A ^a   Bang, C J ^b   Nysaeter G ^b   Hatlebakk, J G ^b   Olafsson, S ^b   Nesje, L B ^b   Hausken, T ^b   Berstad, K ^b   Hundal, O ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH NITRATE; METRONIDAZOLE; OXYTETRACYCLINE; OXYTETRAL; RANITIDINE; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER PYLORI; HUMAN; HYDROGEN BREATH TEST; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH ULCER; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OXYTETRACYCLINE; PALLIATIVE CARE; PEPTIC ULCER; RANITIDINE; TREATMENT OUTCOME;

EID: 0029979323     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tytgat GNJ, Lee A, Graham DY, et al. The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993;6:76-89.
2. Berstad K, Berstad A. Review: Helicobacter pylori infection in peptic ulcer disease. Scand J Gastroenterol 1993;28:561-7.
3. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42.
4. Coghlan JG, Gilligan D, Humphries H, et al. Campylobacter pylori and recurrence of duodenal ulcers: A 12 month follow-up study. Lancet 1987;2:1109-11.
5. Rauws EA, Tygat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;334:1233-5.
6. Patchett S, Beatti SR, Leen E, et al. Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol 1992;87:24-7.
7. Borody TJ, Andrews P, Mancuso N, et al. Helicobacter pylori reinfection rate in patients with cured duodenal ulcer. Am J Gastroenterol 1994;89:529-32.
8. Berstad A, Hatlebakk JG, Wilhelmsen I, et al. Follow-up on 242 patients with peptic ulcer disease one year after eradication of H. pylori infection. Hepatogastroenterology 1995;42:655-9.
9. Chiba N, Rao RV, Rademaker JW, et al. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
10. Wilhelmsen I, Weberg R, Berstad K, et al. Helicobacter pylori eradication and peptic ulcer healing with bismuth subnitrate, oxytetracycline and metronidazole. Hepatogastroenterology 1994;41:43-7.
11. Berstad A, Berstad K, Hatlebakk JG, et al. Ten-day triple treatment for Helicobacter pylori infection and peptic ulcer. Tidsskr Nor Lægeforen 1994;114:2477-9.
12. Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328: 308-12.
13. Rautelin H, Seppälä K, Renkonen O-V, et al. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992;36:163-6.
14. Berstad K, Wilhelmsen I, Berstad A. Biometric evaluation of gastric urease activity in man. Scand J Gastroenterol 1992;27:977-83.
15. Hauer-Jensen M. Sample size calculation, power analysis and randomization: Research project design in Windows. Cabios 1993;9,: 45-47.
16. Nysæter G, Berstad K, Weberg R, et al. Diagnostikk av Helicobacter pylori-infeksjon. Ureasehurtigtest, mikroskopi av utstryk og dyrking fra ventrikkelbiopsi samanlikna med (14)C-urea-pusteprøven. Tidsskr Nor Lægeforen 1992;112:2356-8.
17. MelingT, Steen T, Berstad K. Reproducibility of the (14)C-urea breath test. Gut 1994;35(suppl 4):130.
18. Graham DY, Lew GM, Ramirez FC, et al. A non-metronidazole triple therapy for eradication of Helicobacter pylori infection: Tetracycline, amoxicillin, bismuth. Aliment Pharmacol Ther 1993;7:111-14.
19. Logan RPH, Gummett PA, Misiewicz JJ, et al. One week eradication regimen for H. pylori. Lancet 1991;338:1249-52.
20. Berstad A, Berstad K, Wilhelmsen I, et al. Spiramycin in triple therapy of H. priori-associated peptic ulcer disease. Aliment Pharmacol Ther 1995;9:197-200.
21. De Boer WA, Driessen WMM, Potters HVPJ, et al. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating H. pylori. Am J Gastroenterol 1994;89:1993-7.
22. De Boer W, Driessen W, Jansz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345:817-20.
23. Sung JJY, Chung SC, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-42.